2.73 USD
↗ 0.01 (0.37%)AT CLOSE (11:59 AM EDT)
Genelux Corporation Common Stock
GNLXNASDAQ • USD
2.74
↗ 0.01 (0.40%)
POST MARKET (AS OF 07:36 PM EDT)
Post Market
AS OF 07:36 PM EDT
2.74
↗ 0.01 (0.40%)
Market: CLOSED
GNLX is currently priced at $2.73. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, GNLX is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 26, 2026.
Open?$2.73
High?$2.76
Low?$2.64
Prev. Close?$2.72
Volume?300.2K
Avg. Volume?288.0K
VWAP?$2.71
Rel. Volume?1.04x
Bid / Ask
Bid?$2.64 × 500
Ask?$2.84 × 30.0K
Spread?$0.20
Midpoint?$2.74
Valuation & Ratios
Market Cap?123.5M
Shares Out?45.2M
Float?38.2M
Float %?85.3%
P/E Ratio?N/A
P/B Ratio?7.67
EPS?-$0.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
Themes
Employees
26
Market Cap
123.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-01-26
Address
2625 TOWNSGATE ROAD, SUITE 230
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
WESTLAKE VILLAGE, CA 91361
Phone: 805-267-9889
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?49
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.86Distress
Confidence?55%Low
Short InterestHigh
Short % of Float?9.20%Elevated
Short Interest?3.5M
Days to Cover?8.5
Free Float38.2M
Avg Daily Volume416.2K
Settlement Date2026-08-14
Financial Health
Current Ratio?2.39Strong
Quick Ratio?2.39Strong
Cash Ratio?1.15Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.67FAIR▾
Peers100
S&P24
P/S?15,439.97HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.2CHEAP▾
S&P97
EV/Sales?14,291.97HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-220.9%WEAK▾
S&P3
ROA?-135.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-28683000
Enterprise Value?$114.3M
Fundamentals ratios updated end of day